Jan Fortuniak

Jan Fortuniak

Auto-generated profile, based on publicly available information

Jan Fortuniak

Department of Neurosurgery and Neuro-Oncology, Medical University of Lodz, Barlicki University Hospital, Kopcinskiego St. 22, 90-153 Lodz, Poland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2026 in Journal of Clinical Neuroscience
Verified
Journal Article
Closed access
JFJan Fortuniak
Jan Fortuniak
MHMarlena Hupało
Marlena Hupało
DJDariusz Jan Jaskólski
Dariusz Jan Jaskólski
FKFilip Franciszek Karuga
Filip Franciszek Karuga
SWSora Wanibuchi
Sora Wanibuchi
Bartosz SzmydBartosz Szmyd
Bartosz Szmyd

29 August 2025 in Aktualności Neurologiczne
Verified
Journal Article
Open access
PDF file
MBMaciej Bryl
Maciej Bryl
Bartosz SzmydBartosz Szmyd
Bartosz Szmyd
KWKarol Wiśniewski
Karol Wiśniewski
JFJan Fortuniak
Jan Fortuniak
RWRafał Wójcik
Rafał Wójcik
DJDariusz Jan Jaskólski
Dariusz Jan Jaskólski
Cerebral microdialysis enables bedside assessment of the concentration of selected metabolites in the patient’s brain. The modern microdialysis device consists of a double-lumen probe. Its interior is made of an impermeable material, while the outer layer is a semipermeable membrane through which the tested microdialysate penetrates from the brain. At the end of the probe, there is an opening connecting the outer lumen with the inner lumen, used to deliver the so-called perfusate − a solution isotonic with the brain’s extracellular fluid. Chemical compounds diffuse through the semipermeable membrane of the outer probe according to the concentration gradient, reaching the collection chamber. Therefore, the microdialysis probe placed in the brain parenchyma can be compared to an artificial capillary vessel, where substances are exchanged based on the concentration gradient. The microdialysate reflects the biochemical state of the area in which the probe is placed. There are reports on the benefits of cerebral microdialysis in patients after subarachnoid haemorrhage, traumatic brain injury, and cerebrovascular accidents. Further studies suggest the potential for its use in epilepsy, bacterial meningitis, and in the assessment of drug distribution and pharmacokinetics in the brain. Advances in temporal and spatial resolution create opportunities for the increasingly widespread use of microdialysis in both research and clinical practice. The aim of this study is to describe the principles of microdialysis, discuss examples of its application in clinical practice, and outline the limitations and indications for implanting an intracerebral microdialysis probe.